Nicotine metabolism in young adult daily menthol and nonmenthol smokers

Nicotine and Tobacco Research

Volumn 18, Issue 4, 2016, Pages 437-446

  Fagan, Pebbles ^a   Pokhrel, Pallav ^a   Herzog, Thaddeus A ^a   Pagano, Ian S ^a   Franke, Adrian A ^a   Clanton, Mark S ^b   Alexander, Linda A ^c   Trinidad, Dennis R ^d   Sakuma, Kari Lyn K ^e   Johnson, Carl A ^d   Moolchan, Eric T ^f  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b TMF Health Quality Institute   (United States)

^c UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^d CLAREMONT GRADUATE UNIVERSITY   (United States)

^e OREGON STATE UNIVERSITY   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; BIOLOGICAL MARKER; CARBON MONOXIDE; COTININE; CYTOCHROME P450 2A6; MENTHOL; NICOTINE; TOBACCO SMOKE; HYDROXYCOTININE;

ADULT; AGE; ARTICLE; BODY MASS; CAUCASIAN; COMPARATIVE STUDY; EDUCATION; ENZYME ACTIVITY; ETHNICITY; FEMALE; FILIPINO (PEOPLE); GENDER; HUMAN; MALE; MARRIAGE; MENTHOL SMOKER; METABOLIC RATIO; METABOLISM; NATIVE HAWAIIAN; NICOTINE METABOLISM; NICOTINE METABOLITE RATIO; NONMENTHOL SMOKER; PASSIVE SMOKING; PRIORITY JOURNAL; SALIVA LEVEL; SMOKING; SMOKING CESSATION; SMOKING HABIT; TOBACCO CONSUMPTION; YOUNG ADULT; ADOLESCENT; ANALOGS AND DERIVATIVES; ANALYSIS; CHEMISTRY; ETHNOLOGY; SALIVA; TOBACCO;

ADOLESCENT; ADULT; BIOMARKERS; CARBON MONOXIDE; COTININE; FEMALE; HUMANS; MALE; MENTHOL; NICOTINE; SALIVA; SMOKING; TOBACCO PRODUCTS; YOUNG ADULT;

EID: 84963829835     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv109     Document Type: Article

References (58)

1. U.S. Department of Health and Human Services. The Health Consequences of Smoking- 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57(45):1226-1228. www.ncbi.nlm.nih.gov.eres.library.manoa.hawaii.edu/pubmed/ 19008791. Accessed February 17, 2015.
3. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
4. Míguez-Burbano MJ, Vargas M, Quiros C, Lewis JE, Espinoza L, Deshratan A. Menthol cigarettes and the cardiovascular risks of people living with HIV. J Assoc Nurses AIDS Care. 2014;25(5):427-435. doi:10.1016/j.jana.2014.01.006.
5. Giovino GA, Villanti AC, Mowery PD, et al. Differential trends in cigarette smoking in the USA: is menthol slowing progress? Tob Control. 2015;24(1):28-37. doi:10.1136/tobaccocontrol-2013-051159.
6. Lawrence D, Rose A, Fagan P, Moolchan ET, Gibson JT, Backinger CL. National patterns and correlates of mentholated cigarette use in the United States. Addiction. 2010;105(suppl 1):13-31. doi:10.1111/j.1360-0443.2010.03203.x.
7. Rock VJ, Davis SP, Thorne SL, Asman KJ, Caraballo RS. Menthol cigarette use among racial and ethnic groups in the United States, 2004-2008. Nicotine Tob Res. 2010;12(suppl 2):S117-124. doi:10.1093/ntr/ ntq204.
8. Ferris WG, Connolly GN. Application, function, and effects of menthol in cigarettes: a survey of tobacco industry documents. Nicotine Tob Res. 2004;6(suppl 1):S43-54. doi:10.1080/14622203310001649513.
9. Doll R, Peto R, Boreham J, Sutherland I. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer. 2005;92(3):426-429. doi:10.1038/sj.bjc.6602359.
10. Tobacco Products Scientific Advisory Committee. Menthol cigarettes and public health: Review of the scientific evidence and recommendations. 2011. www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/TobaccoProductsScientificAdvisory Committee/UCM269697.pdf. Accessed March 26, 2014.
11. Food and Drug Administration. Preliminary scientific evaluation of the possible public health effects of menthol versus non-menthol cigarettes. 2013. www.fda.gov/downloads/ScienceResearch/.../UCM361598.pdf>. Accessed October 8, 2013.
12. Okuyemi KS, Faseru B, Sanderson Cox L, Bronars CA, Ahluwalia JS. Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction. 2007;102(12):1979-1986. doi:10.1111/j.1360-0443.2007.02010.x.
13. Smith SS, Fiore MC, Baker TB. Smoking cessation in smokers who smoke menthol and non-menthol cigarettes. Addiction. 2014;109(12):2107-2117. doi:10.1111/add.12661.
14. MacDougall JM, Fandrick K, Zhang X, Serafin SV, Cashman JR. Inhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analogues. Chem Res Toxicol. 2003;16(8):988-993. doi:10.1021/tx0340551.
15. Benowitz NL, Herrera B, Jacob P III. Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther. 2004;310(3):1208-1215. doi:10.1124/jpet.104.066902.
16. Messina ES, Tyndale RF, Sellers EM. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther. 1997;282(3):1608-14. www.ncbi.nlm.nih.gov.eres.library.manoa.hawaii. edu/pubmed/9316878 Accessed February 17, 2015.
17. Benowitz NL, Jacob P III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994;56(5):483-493. doi:10.1038/clpt.1994.169.
18. Hukkanen J, Jacob P III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57(1):79-115. doi:10.1124/ pr.57.1.3.
19. Benowitz NL, Jacob P III, Fong I, Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther.1994;268(1):296-303. www.ncbi.nlm.nih.gov.eres. library.manoa.hawaii.edu/pubmed/8301571. Accessed February 17, 2015.
20. Dempsey D, Tutka P, Jacob P III, et al. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther. 2004;76(1):64-72. doi:10.1016/j.clpt.2004.02.011.
21. Mwenifumbo JC, Al Koudsi N, Ho MK, et al. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. Hum Mutat. 2008;29(5):679-688. doi:10.1002/ humu.20698.
22. Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1812-1819. doi:10.1158/1055-9965.EPI-05-0723.
23. Johnstone E, Benowitz N, Cargill A, et al. Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin Pharmacol Ther. 2006;80(4):319-330. doi:10.1016/j.clpt.2006.06.011.
24. Ho MK, Mwenifumbo JC, Al Koudsi N, et al. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. Clin Pharmacol Ther. 2009;85(6):635-643. doi:10.1038/clpt.2009.19.
25. Nakajima M, Yamamoto T, Nunoya K, et al. Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther. 1996;277(2):1010-1015. www.ncbi.nlm.nih.gov. eres.library.manoa.hawaii.edu/pubmed/8627511 Accessed February 17, 2015.
26. Zhu AZ, Zhou Q, Cox LS, Ahluwalia JS, Benowitz NL, Tyndale RF. Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake. PLoS One. 2013;8(8):e70938. doi:10.1371/journal.pone.0070938.
27. Lea RA, Dickson S, Benowitz NL. Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate. J Anal Toxicol. 2006;30(6):386-389. doi:10.1093/jat/30.6.386.
28. St Helen G, Jacob P III, Benowitz NL. Stability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes. Nicotine Tob Res. 2013;15(11):1939-1942. doi:10.1093/ntr/ntt065.
29. St Helen G, Novalen M, Heitjan DF, et al. Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer Epidemiol Biomarkers Prev. 2012;21(7):1105-1114. doi:10.1158/1055-9965.EPI-12-0236.
30. Chenoweth MJ, Novalen M, Hawk LW Jr, et al. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiol Biomarkers Prev. 2014;23(9):1773-1782. doi:10.1158/1055-9965.EPI-14-0427.
31. Benowitz NL, Dains KM, Dempsey D, Wilson M, Jacob P. Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob Res. 2011;13(9):772-783. doi:10.1093/ntr/ntr072.
32. Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res. 2007;9(8):873-881. doi:10.1080/14622200701484995.
33. Sarkar M, Wang J, Liang Q. Metabolism of nicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone (NNK) in menthol and non-menthol cigarette smokers. Drug Metab Lett. 2012;6(3):198-206. doi:10.2174/1872312811206030007.
34. Lerman C, Tyndale R, Patterson F, et al. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther. 2006;79(6):600-608. doi:10.1016/j.clpt.2006.02.006.
35. Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav. 2009;92(1):6-11. doi:10.1016/j.pbb.2008.10.016.
36. Chen LS, Bloom AJ, Baker TB, et al. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). Addiction. 2014;109(1):128-137. doi:10.1111/add.12353.
37. Styn MA, Nukui T, Romkes M, Perkins KA, Land SR, Weissfeld JL. CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer. Subst Use Misuse. 2013;48(7):490-494. doi:10.3109/10826084.2013.778280.
38. Faseru B, Nollen NL, Mayo MS, et al. Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial. Addict Behav. 2013;38(3):1796-1803. doi:10.1016/j.addbeh.2012.11.010.
39. Smoking and Tobacco in Hawaii. Figures and Trends. 2010. http:// hawaii.gov/health/healthy-lifestyles/tobacco/resources/general/trends.pdf. Accessed August 3, 2014.
40. Ramo DE, Rodriguez TM, Chavez K, Sommer MJ, Prochaska JJ. Facebook recruitment of young adult smokers for a cessation trial: methods, metrics, and lessons learned. Internet Interv. 2014;1(2):58-64. doi:10.1016/j. invent.2014.05.001.
41. Ramo DE, Hall SM, Prochaska JJ. Reaching young adult smokers through the internet: comparison of three recruitment mechanisms. Nicotine Tob Res. 2010;12(7):768-775. doi:10.1093/ntr/ntq086.
42. Ramo DE, Prochaska JJ. Broad reach and targeted recruitment using Facebook for an online survey of young adult substance use. J Med Internet Res. 2012;14(1):e28. doi:10.2196/jmir.1878.
43. 2010-2011 Tobacco Use Supplement to the Current Population Survey. http://riskfactor.cancer.gov/studies/tus-cps/info.html. Accessed March 20, 2014.
44. Williams DR, Yu Y, Jackson JS, Anderson NB. Racial differences in physical and mental health: socio-economic status, stress and discrimination. J Health Psychol. 1997;2(3):335-351. doi:10.1177/135910539700200305.
45. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-396. doi:http://dx.doi. org/10.2307/2136404.
46. Shakleya DM, Huestis MA. Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877(29):3537-3542. doi:10.1016/j.jchromb.2009.08.033.
47. SAS Institute Inc. SAS® 9.4 System Options: Reference, Second Edition. Cary, NC: SAS Institute Inc; 2011.
48. Levi M, Dempsey DA, Benowitz NL, Sheiner LB. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application. J Pharmacokinet Pharmacodyn. 2007;34(1):23-34. doi:10.1007/s10928-006-9026-0.
49. Derby KS, Cuthrell K, Caberto C, et al. Nicotine metabolism in three ethnic/ racial groups with different risks of lung cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3526-3535. doi:10.1158/1055-9965. EPI-08-0424.
50. Mooney ME, Li ZZ, Murphy SE, Pentel PR, Le C, Hatsukami DK. Stability of the nicotine metabolite ratio in ad libitum and reducing smokers. Cancer Epidemiol Biomarkers Prev. 2008;17(6):1396-1400. doi:10.1158/1055-9965.EPI-08-0242.
51. St Helen G, Novalen M, Heitjan DF, et al. Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer Epidemiol Biomarkers Prev. 2012;21(7):1105-1114. doi:10.1158/1055-9965. EPI-12-0236.
52. Ahijevych K, Parsley LA. Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addict Behav. 1999;24(1):115-120. doi:10.1016/S0306-4603(98)00031-8.
53. Lewis MJ, Wackowski O. Dealing with an innovative industry: a look at flavored cigarettes promoted by mainstream brands. Am J Public Health. 2006;96(2):244-251. doi:10.2105/AJPH.2004.061200.
54. Trinidad DR, Pérez-Stable EJ, Messer K, White MM, Pierce JP. Menthol cigarettes and smoking cessation among racial/ethnic groups in the United States. Addiction. 2010;105(suppl 1):84-94. doi:10.1111/ j.1360-0443.2010.03187.x.
55. Stahre M, Okuyemi KS, Joseph AM, Fu SS. Racial/ethnic differences in menthol cigarette smoking, population quit ratios and utilization of evidence-based tobacco cessation treatments. Addiction. 2010;105(suppl 1):75-83. doi:10.1111/j.1360-0443.2010.03200.x.
56. Mwenifumbo JC, Sellers EM, Tyndale RF. Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking. Drug Alcohol Depend. 2007;89(1):24-33. doi:http://dx.doi.org/10.1016/j.drugalcdep.2006.11.012.
57. Wang J, Roethig HJ, Appleton S, Werley M, Muhammad-Kah R, Mendes P. The effect of menthol containing cigarettes on adult smokers' exposure to nicotine and carbon monoxide. Regul Toxicol Pharmacol. 2010;57(1):24-30. doi:10.1016/j.yrtph.2009.12.003.
58. Benowitz NL, Dains KM, Dempsey D, Havel C, Wilson M, Jacob P III. Urine menthol as a biomarker of mentholated cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3013-3019. doi:10.1158/1055-9965.EPI-10-0706.